# mySugr

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mysugr

- Industry: Software
- Headquarters: Vienna, Austria
- Website: www.mysugr.com
- Total disclosed funding: $4.8M
- Latest round: Seed (Mar 11, 2015)
- Investors on record: 3

## About

mySugr GmbH is a technology firm that specializes in creating digital solutions for diabetes management, enabling users to track their health data seamlessly and effectively.Founded in 2012 by Michael Forisch, mySugr GmbH is headquartered in Vienna, Austria. The company is known for its comprehensive diabetes management application, which has seen significant adoption across various markets. In June 2017, Roche acquired mySugr for an undisclosed amount, marking a pivotal moment in its business trajectory. The company has engaged in 4 total deals, with the most recent funding round being a Seed round in which it raised USD 4.80 mn from investors including Roche Venture Fund, XLHealth Corporation, and iSeed Ventures.mySugr offers a diabetes management application tailored for users living with diabetes, enabling them to log crucial therapy data efficiently. The app integrates with various diabetes devices for automatic data logging, includes features like food logging with Meal Photos, and supports over six million registered accounts worldwide, primarily in the United States and Europe.In the most recent fiscal year 2023, mySugr reported revenue of USD 26.04 mn and an EBITDA of USD 4.16 mn. The company's revenue model is based on a freemium structure, with basic functionalities offered for free and a premium subscription tier providing advanced features.Following its acquisition by Roche in June 2017, mySugr plans to leverage its recent funding to enhance its product offerings and expand into new markets. The company is focused on developing new features and tools to improve user engagement within its application. Specific plans for geographic expansion include increasing its presence in emerging markets across Europe and North America, aiming for substantial growth over the coming years.

## Funding rounds

- Seed, Mar 11, 2015, $4.8M — XLHealth Corporation, Roche Venture Fund, iSeed Ventures

## Investors

- XLHealth Corporation — Seed
- Roche Venture Fund (https://capitalatlas.ai/funds/roche-venture-fund) — Seed
- iSeed Ventures (https://capitalatlas.ai/funds/iseed-ventures) — Seed